FLGR242 (10mg)

All orders will be shipped in January

FLGR242

• Composition and Format

FLGR242 is a synthetic research peptide provided as a 10 mg lyophilized powder in a single vial. Each batch is accompanied by a Certificate of Analysis (COA) documenting sequence confirmation, lot specifications, and formulation details to support method reproducibility and record-keeping.

• Analytical Verification

Every lot undergoes analytical qualification, including ≥99% purity verification by high-performance liquid chromatography (HPLC) and identity confirmation by mass spectrometry. Select batches may also be evaluated by independent third-party laboratories to validate internal analytical results for traceable research-grade documentation.

• Intended Research Use

FLGR242 is used exclusively in controlled laboratory settings for in-vitro research focused on fibroblast-related molecular processes, cell–matrix interactions, and extracellular matrix organization. All technical descriptions relate strictly to laboratory methodology and do not reference diagnostic, therapeutic, or performance outcomes.

• Research Characteristics and Applications

This peptide analog contains a defined sequence that mirrors fibroblast-modulating motifs studied in extracellular matrix formation and cellular communication. In structured in-vitro models, investigators use FLGR242 to explore matrix protein organization, cell-signaling dynamics, and fibroblast-mediated structural assembly. Its sequence fidelity and reproducible laboratory behavior support studies involving microenvironment modeling and pathway characterization.

• Manufacturing and Documentation

Helios Bio Pro’s research materials, including FLGR242, are manufactured by Alpha BioMed Labs in the United States under defined quality procedures and research-only labeling. Batch documentation—including COAs, supplier verification records, and raw-material provenance—is maintained to support institutional review and audit-ready compliance.